Ann: Alcidion Appendix 4C - quarterly, page-27

It wasn't long before Christmas that we had news on the "ramp up" of commercialising the offerings to the market. Sales into this industry through Dec / Jan is very slow due to key decision makers not being around to make said decisions (see last years results). Anything coming in off the new focus of the announcement will be 6 months (average sales cycle length) from that time, earlier if they inherited anything from the recent acquisition (very likely imo). New directors / staff would also need on-board training etc which takes time.

So I guess what I'm saying is that a few here need to take a chill pill imo. If management have information on these things they need to tell us, it is fair enough imo to think Calvary is still being worked on and I would expect details in the near future as per their guidance that it was being deployed in Q2. (deployed, not finalised and announced).

Now I'm going to take a slightly different angle here after comparing the 8 pages of information in Q1 to the 2 pages this quarter it looks to me that there may have been some time constraints in getting it out. This theory matches the fact that it was received at the last moment and is somewhat short. We know a lot is going on and that Nathan Buzza was likely looking after these announcements before his departure, so they get the benefit of the doubt from me. Hopefully it means they are working flat chat on something big. I will however be (as some others here are probably doing) contacting management for clarification on the lack of detail in the quarterly... but I still have as much faith today as I did yesterday, and the day before that. And really, who expected the quarterly to be huge news this quarter anyway? And if you did? Why? Did I miss an announcement?